Abstract
The present study was designed to construct a recombinant adeno-associated virus (rAAV) which can express NAP in the brain and examine whether this virus can produce antidepressant effects on C57 BL/6 mice that had been subjected to open field test and forced swimming test, via nose-to-brain pathway. When the recombinant plasmid pGEM-T Easy/NT4-NAP was digested by EcoRI, 297 bp fragments can be obtained and NT4-NAP sequence was consistent with the designed sequence confirmed by DNA sequencing. When the recombinant plasmid pSSCMV/NT4-NAP was digested by EcoRI, 297 bp fragments is visible. Immunohistochemical staining of fibroblasts revealed that expression of NAP was detected in NT4-NAP/AAV group. Intranasal delivery of NT4-NAP/AAV significantly reduced immobility time when the FST was performed after 1 day from the last administration. The effects observed in the FST could not be attributed to non-specific increases in activity since intranasal delivery of NT4-NAP/AAV did not alter the behavior of the mice during the open field test. The results indicated that a recombinant AAV vector which could express NAP in cells was successfully constructed and NAP may be a potential target for therapeutic action of antidepressant treatment.
| Original language | English |
|---|---|
| Pages (from-to) | 1375-1380 |
| Number of pages | 6 |
| Journal | Neurochemical Research |
| Volume | 41 |
| Issue number | 6 |
| DOIs | |
| State | Published - 1 Jun 2016 |
| Externally published | Yes |
Keywords
- Depression
- FST
- Intranasal administration
- NAP
- NT4-NAP/AAV
- OFT
Fingerprint
Dive into the research topics of 'Intranasal Delivery of Recombinant NT4-NAP/AAV Exerts Potential Antidepressant Effect'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver